DNA tests that cost as much as $750 claim to tell you which antidepressant is best for you, but scientists say they're not worth the money
- And Cristina Cusin, a Harvard psychiatrist, said the test won't give helpful results to patients who take more than one medication.
- Despite trying more than two dozen different medications, Luk and her psychiatrists had yet to come up with a combination of drugs that significantly lifted her mood without contributing to her anxiety.
- Next to a popular antidepressant called Celexa, for example, Luk's test showed an orange check mark and said, "increased risk for adverse events or poor response." That meant that because of the way her body processed the drug, Luk was more likely than the average person to experience negative side effects or see no positive results.
- Last month, Silicon Valley genetics testing startup Color Genomics began offering a test for antidepressants as a component of its DNA tests, which screen for gene variations linked to cancer and heart disease.
Three untapped opportunities wearables present to health insurers, providers, and employers
- In turn, insurers, providers, and employers are poised to become just as active leveraging these devices - and the data they capture - to abandon the traditional reimbursement model and improve patient outcomes with personalized, value-based care.
- A new report from Business Insider Intelligence, Business Insider's premium research service, follows the growing adoption of wearables and breadth of functions they offer to outline how healthcare organizations and stakeholders can overcome this challenge and add greater value with wearable technology.
- It explores the key drivers behind wearable usage by insurers, healthcare providers, and employers, and the opportunities wearables afford to each of these stakeholders.
- By outlining a successful case study from each stakeholder, the report highlights best practices in implementing wearables to reduce healthcare claims, improve patient outcomes, and drive insurance cost savings, as well as how the evolution of the market will create new, untapped opportunities for businesses.
How Alphabet, Amazon, Apple, and Microsoft are shaking up healthcare — and what it means for the future of the industry
- The potential for tech-led digital health initiatives to help healthcare providers and insurers deliver safer, more efficient, and cost-effective care is significant.
- For their part, the "Big Four" tech companies — Google-parent Alphabet, Amazon, Apple, and Microsoft — see an opportunity to tap into the lucrative health market.
- In this report, Business Insider Intelligence explores the key strengths and offerings the Big Four will bring to the healthcare industry, as well as their approaches into the market.
- Finally, the report will outline the barriers that are inhibiting the adoption and usage of the Big Four tech companies' offerings and how these barriers can be circumvented.
- Companies included in this report: Alphabet, Amazon, Apple, Microsoft, Facebook, FitBit, MyFitnessPal, Verily Life Sciences, Calico, DeepMind, Merck, Berkshire Hathaway, JPMorgan Chase, Retail Pharmaceuticals, PillPack, Aetna, UnitedHealthcare, John Hancock.
10 ways medical marijuana can be used to treat disease
- People use it to treat a variety of medical issues, such as multiple sclerosis, arthritis, epilepsy, glaucoma, HIV, chronic pain, Alzheimer's, cancer and others.
- Another small study of 50 people found patients that smoked cannabis saw less neuropathic pain.
- Some medicines based on cannabis such as Sativex are being tested on multiple sclerosis patients and used to treat cancer pain.
- In another trial involving 56 human patients, scientists saw a 30% reduction in pain in those who smoked marijuana.
- In a small pilot study of 13 patients watched over three months, researchers found inhaled cannabis did improve life for people suffering from ulcerative colitis and Crohn's disease.
- Using marijuana or some of the chemicals in the plant may help prevent muscle spasms, pain, tremors and stiffness, according to early-stage, mostly observational studies involving animals, lab tests and a small number of human patients.
University of Central Florida’s AI finds early lung cancer with up to 97% sensitivity
- Using a convolutional neural network (CNN) — a layered machine learning model that mimics the behavior of nuerons in the human brain — researchers at the University of Florida’s Center for Research in Computer Vision (CRCV) were able to identify small nodules of lung cancer with 95 to 97 percent sensitivity.
- Their work builds on that of NYU researchers in September, who retrained Google’s Inception v3, an open source convolutional neural network architected for object identification, to detect certain forms of lung cancers with 97 percent accuracy.
- The S4ND was demonstrably better at handling the variation in textures, shapes, and position of nodules than traditional computer-aided detection systems, the researchers wrote, and had an easier time reconciling discrepancies between large search spaces (i.e., the entire lung) and the comparatively small nodes.
Health officials warn that a rare polio-like disease affecting children continues to spread, growing to a suspected 127 cases in 22 states
- The outbreak of a polio-like disease called Acute Flaccid Myelitis (AFM) keeps growing, and medical experts are still baffled as to what is causing the spike of the very rare illness.
- Officials with the Centers for Disease Control and Prevention held a conference call on Tuesday, revealing that the number of suspected AFM cases has grown to 127, with 62 of those cases confirmed in 22 states.
- AFM is a condition that mostly affects young children, with 90% of the cases in this recent outbreak affecting those under the age of 18.
- It's believed that viruses like polio, West Nile, and various enteroviruses (which cause the common cold) have been linked to AFM.
- The children involved in this outbreak have tested negative for polio and West Nile, and there are no other common viruses that seem to link them together.